Refine
Has Fulltext
- yes (1003) (remove)
Year of publication
- 2019 (1003) (remove)
Document Type
- Journal article (448)
- Doctoral Thesis (413)
- Complete part of issue (51)
- Book article / Book chapter (33)
- Preprint (19)
- Book (13)
- Working Paper (8)
- Master Thesis (4)
- Report (3)
- Study Thesis (term paper) (3)
Language
- English (637)
- German (362)
- Multiple languages (2)
- Russian (1)
- Spanish (1)
Keywords
- Universität (47)
- Wuerzburg (47)
- Würzburg (47)
- University (46)
- Wurzburg (46)
- Animal Studies (24)
- Cultural Animal Studies (24)
- Cultural Studies (24)
- Ecocriticism (24)
- Environmental Humanities (24)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (96)
- Graduate School of Life Sciences (69)
- Physikalisches Institut (46)
- Universität - Fakultätsübergreifend (46)
- Institut für deutsche Philologie (39)
- Institut für Anorganische Chemie (38)
- Institut für Organische Chemie (35)
- Medizinische Klinik und Poliklinik II (35)
- Medizinische Klinik und Poliklinik I (34)
- Neuphilologisches Institut - Moderne Fremdsprachen (33)
- Institut für Psychologie (30)
- Neurologische Klinik und Poliklinik (30)
- Kinderklinik und Poliklinik (29)
- Institut für Geographie und Geologie (27)
- Institut für Pharmazie und Lebensmittelchemie (25)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (25)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (22)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (21)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (21)
- Institut für Hygiene und Mikrobiologie (19)
- Rudolf-Virchow-Zentrum (19)
- Institut für Informatik (18)
- Julius-von-Sachs-Institut für Biowissenschaften (18)
- Institut für Physikalische und Theoretische Chemie (17)
- Institut für Virologie und Immunbiologie (17)
- Institut für Theoretische Physik und Astrophysik (16)
- Lehrstuhl für Orthopädie (16)
- Pathologisches Institut (16)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (14)
- Klinik und Poliklinik für Nuklearmedizin (14)
- Klinik und Poliklinik für Strahlentherapie (14)
- Betriebswirtschaftliches Institut (13)
- Institut für Klinische Epidemiologie und Biometrie (13)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (13)
- Institut für Anatomie und Zellbiologie (11)
- Institut für Funktionsmaterialien und Biofabrikation (11)
- Institut für Humangenetik (11)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (11)
- Institut für Pharmakologie und Toxikologie (10)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (10)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (10)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (10)
- Neurochirurgische Klinik und Poliklinik (10)
- Institut für Klinische Neurobiologie (9)
- Medizinische Fakultät (9)
- Institut für Mathematik (8)
- Institut für Molekulare Infektionsbiologie (8)
- Institut für Politikwissenschaft und Soziologie (8)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (8)
- Graduate School of Science and Technology (7)
- Institut Mensch - Computer - Medien (7)
- Institut für Experimentelle Biomedizin (7)
- Institut für Geschichte der Medizin (7)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (7)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (7)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (6)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (6)
- Fakultät für Biologie (5)
- Institut für Altertumswissenschaften (5)
- Institut für Sportwissenschaft (5)
- Lehrstuhl für Biochemie (5)
- Universität Würzburg (5)
- Augenklinik und Poliklinik (4)
- Fakultät für Humanwissenschaften (Philos., Psycho., Erziehungs- u. Gesell.-Wissensch.) (4)
- Institut für Geschichte (4)
- Philosophische Fakultät (Histor., philolog., Kultur- und geograph. Wissensch.) (4)
- Sportzentrum (4)
- Urologische Klinik und Poliklinik (4)
- Volkswirtschaftliches Institut (4)
- Comprehensive Cancer Center Mainfranken (3)
- Institut für Biblische Theologie (3)
- Institut für Internationales Recht, Europarecht und Europäisches Privatrecht (3)
- Institut für Kulturwissenschaften Ost- und Südasiens (3)
- Institut für Musikforschung (3)
- Institut für Psychotherapie und Medizinische Psychologie (3)
- Physiologisches Institut (3)
- Center for Computational and Theoretical Biology (2)
- Frauenklinik und Poliklinik (2)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (2)
- Institut für Medizinische Strahlenkunde und Zellforschung (2)
- Institut für Pädagogik (2)
- Institut für Sonderpädagogik (2)
- Klinik und Polikliniken für Zahn-, Mund- und Kieferkrankheiten (2)
- Missionsärztliche Klinik (2)
- Poliklinik für Zahnerhaltung und Parodontologie (2)
- Abteilung für Forensische Psychiatrie (1)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (1)
- Institut für Allgemeinmedizin (1)
- Institut für Archäologie (1)
- Institut für Bürgerliches Recht und Zivilprozessrecht (1)
- Institut für Kunstgeschichte (1)
- Institut für Philosophie (1)
- Institut für Praktische Theologie (1)
- Institut für Slavistik (1)
- Institut für Strafrecht und Kriminologie (1)
- Institut für Systemimmunologie (1)
- Lehrstuhl für Molekulare Psychiatrie (1)
- Martin-von-Wagner-Museum (1)
- Poliklinik für Kieferorthopädie (1)
- Rechenzentrum (1)
- Universitätsbibliothek (1)
Schriftenreihe
Sonstige beteiligte Institutionen
- VolkswagenStiftung (24)
- DFG Forschungsgruppe 2757 / Lokale Selbstregelungen im Kontext schwacher Staatlichkeit in Antike und Moderne (LoSAM) (2)
- Deutsches Archäologisches Institut (2)
- Johns Hopkins School of Medicine (2)
- Universität Bayreuth (2)
- Universität Leipzig (2)
- Akademie der Wissenschaften und der Literatur, Mainz (1)
- Bio-Imaging Center Würzburg (1)
- CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - the development agency of the Brazilian Federal Government (1)
- Center for Nanosystems Chemistry (CNC), Universität Würzburg (1)
ResearcherID
- B-4606-2017 (1)
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
The mechanisms behind carbon dioxide (CO2) dependency in non-autotrophic bacterial isolates are unclear. Here we show that the Staphylococcus aureus mpsAB operon, known to play a role in membrane potential generation, is crucial for growth at atmospheric CO2 levels. The genes mpsAB can complement an Escherichia coli carbonic anhydrase (CA) mutant, and CA from E. coli can complement the S. aureus delta-mpsABC mutant. In comparison with the wild type, S. aureus mps mutants produce less hemolytic toxin and are less virulent in animal models of infection. Homologs of mpsA and mpsB are widespread among bacteria and are often found adjacent to each other on the genome. We propose that MpsAB represents a dissolved inorganic carbon transporter, or bicarbonate concentrating system, possibly acting as a sodium bicarbonate cotransporter.
The NEDD8-activating enzyme (NAE) inhibitor MLN4924 inhibits cullin-RING ubiquitin ligase complexes including the SKP1-cullin-F-box E3 ligase βTrCP. MLN4924 therefore inhibits also the βTrCP-dependent activation of the classical and the alternative NFĸB pathway. In this work, we found that a subgroup of multiple myeloma cell lines (e.g., RPMI-8226, MM.1S, KMS-12BM) and about half of the primary myeloma samples tested are sensitized to TNF-induced cell death by MLN4924. This correlated with MLN4924-mediated inhibition of TNF-induced activation of the classical NFκB pathway and reduced the efficacy of TNF-induced TNFR1 signaling complex formation. Interestingly, binding studies revealed a straightforward correlation between cell surface TNFR1 expression in multiple myeloma cell lines and their sensitivity for MLN4924/TNF-induced cell death. The cell surface expression levels of TNFR1 in the investigated MM cell lines largely correlated with TNFR1 mRNA expression. This suggests that the variable levels of cell surface expression of TNFR1 in myeloma cell lines are decisive for TNF/MLN4924 sensitivity. Indeed, introduction of TNFR1 into TNFR1-negative TNF/MLN4924-resistant KMS-11BM cells, was sufficient to sensitize this cell line for TNF/MLN4924-induced cell death. Thus, MLN4924 might be especially effective in myeloma patients with TNFR1+ myeloma cells and a TNFhigh tumor microenvironment.
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44–1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.
Surgical extrusion is a recognised treatment option for teeth that have insufficient coronal tooth structure remaining due to deep caries, resorption or traumatic injury. However, the technique has not been widely adopted, arguably because extraction of a severely compromised tooth may be difficult to achieve in a gentle and predictable way. In this paper, we present our novel approach to surgical extrusion and subsequent management of teeth using a vertical extraction system (Benex), which has become the method of choice in the authors' practice for many teeth that would otherwise be deemed unrestorable. We describe the clinical procedure in detail and discuss the advantages and disadvantages compared to alternative approaches, including surgical crown lengthening and orthodontic extrusion.
C9ORF72 mutations are the most common cause of familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). MRI studies have investigated structural changes in C9ORF72-associated FTLD (C9FTLD) and provided first insights about a prominent involvement of the thalamus and the cerebellum. Our multicenter, 18F-fluorodeoxyglucose positron-emission tomography study of 22 mutation carriers with FTLD, 22 matched non-carriers with FTLD, and 23 cognitively healthy controls provided valuable insights into functional changes in C9FTLD: compared to non-carriers, mutation carriers showed a significant reduction of glucose metabolism in both thalami, underscoring the key role of the thalamus in C9FTLD. Thalamic metabolism did not correlate with disease severity, duration of disease, or the presence of psychotic symptoms. Against our expectations we could not demonstrate a cerebellar hypometabolism in carriers or non-carriers. Future imaging and neuropathological studies in large patient cohorts are required to further elucidate the central role of the thalamus in C9FTLD.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. In this largest exome-wide study of rare variants in ALS to date, we performed single-variant association testing, gene-based burden, and exome-wide individual set-unique burden (ISUB) testing to identify single or aggregated rare variation that modifies disease risk. In single-variant testing no variants reached exome-wide significance, likely due to limited statistical power. Gene-based burden testing of rare non-synonymous and loss-of-function variants showed NEK1 as the top associated gene. ISUB analysis did not show an increased exome-wide burden of deleterious variants in patients, possibly suggesting a more region-specific role for rare variation. Complete summary statistics are released publicly. This study did not implicate new risk loci, emphasizing the immediate need for future large-scale collaborations in ALS that will expand available sample sizes, increase genome coverage, and improve our ability to detect rare variants associated to ALS.
MYC paralogs are frequently activated in small cell lung cancer (SCLC) but represent poor drug targets. Thus, a detailed mapping of MYC-paralog-specific vulnerabilities may help to develop effective therapies for SCLC patients. Using a unique cellular CRISPR activation model, we uncover that, in contrast to MYCN and MYCL, MYC represses BCL2 transcription via interaction with MIZ1 and DNMT3a. The resulting lack of BCL2 expression promotes sensitivity to cell cycle control inhibition and dependency on MCL1. Furthermore, MYC activation leads to heightened apoptotic priming, intrinsic genotoxic stress and susceptibility to DNA damage checkpoint inhibitors. Finally, combined AURK and CHK1 inhibition substantially prolongs the survival of mice bearing MYC-driven SCLC beyond that of combination chemotherapy. These analyses uncover MYC-paralog-specific regulation of the apoptotic machinery with implications for genotype-based selection of targeted therapeutics in SCLC patients.
Animals must slow or halt locomotion to integrate sensory inputs or to change direction. In Caenorhabditis elegans, the GABAergic and peptidergic neuron RIS mediates developmentally timed quiescence. Here, we show RIS functions additionally as a locomotion stop neuron. RIS optogenetic stimulation caused acute and persistent inhibition of locomotion and pharyngeal pumping, phenotypes requiring FLP-11 neuropeptides and GABA. RIS photoactivation allows the animal to maintain its body posture by sustaining muscle tone, yet inactivating motor neuron oscillatory activity. During locomotion, RIS axonal Ca2+ signals revealed functional compartmentalization: Activity in the nerve ring process correlated with locomotion stop, while activity in a branch correlated with induced reversals. GABA was required to induce, and FLP-11 neuropeptides were required to sustain locomotion stop. RIS attenuates neuronal activity and inhibits movement, possibly enabling sensory integration and decision making, and exemplifies dual use of one cell across development in a compact nervous system.
Coordinated regulation of the lysosomal and autophagic systems ensures basal catabolism and normal cell physiology, and failure of either system causes disease. Here we describe an epigenetic rheostat orchestrated by c-MYC and histone deacetylases that inhibits lysosomal and autophagic biogenesis by concomitantly repressing the expression of the transcription factors MiT/TFE and FOXH1, and that of lysosomal and autophagy genes. Inhibition of histone deacetylases abates c-MYC binding to the promoters of lysosomal and autophagy genes, granting promoter occupancy to the MiT/TFE members, TFEB and TFE3, and/or the autophagy regulator FOXH1. In pluripotent stem cells and cancer, suppression of lysosomal and autophagic function is directly downstream of c-MYC overexpression and may represent a hallmark of malignant transformation. We propose that, by determining the fate of these catabolic systems, this hierarchical switch regulates the adaptive response of cells to pathological and physiological cues that could be exploited therapeutically.